title: Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA.
authors.forename: L
authors.initials: L
authors.lastname: Newman
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D007255:Information Services / Q000331:legislation & jurisprudence* / Q000639:trends; D017410:Practice Guidelines as Topic; D014481:United States; D014486:United States Food and Drug Administration